(Good Things Utah) For many, intimacy is the key to a strong relationship. Finding spontaneous moments as a couple can reignite passions and build closer connections overall. But sadly for men with ED (erectile dysfunction), these moments are few and far between, affecting both members of the relationship.
Studies show that there are over 30 million men in the United States alone suffering from some form of ED, with 71 percent of those not seeking any treatment. And it’s easy to understand why. The past 30 years of treatments for ED have involved the use of invasive injections, surgeries, and medications bringing with them a whole host of unintended side effects.
Advances in medical technology have resulted in a breakthrough treatment for men’s ED called Acoustic Wave Therapy. This treatment — performed by Wasatch Medical Clinic — works by using gentle pressure waves that travel through the skin and into the blood vessels, causing them to expand and helping them repair.
After only 2 to 4 brief and painless treatments, patients notice lasting results in the bedroom without the use of any additional support. Even better, their partners are often the first to notice how effective AWT is and appreciate the restored sense of spontaneity in their relationships.
According to Miles Broadhead with Wasatch Medical Clinic: “It works! About 70 to 90 percent of men who are good candidates (most men) are responding in ways that are amazing. They’re not coming back to us — which is good news… We hope that you don’t need us again after we’ve given you the treatment.”
Call Wasatch Medical Clinic today for a FREE exam, assessment, and blood flow ultrasound. Plus, get a bonus gift for those intimate moments with that special someone.
To learn more and book online, go to WasatchMedicalClinic.com.
Visit one of their two Utah locations in Murray and St. George.
310 E 4500 S, Suite 410
1490 Foremaster Dr, Suite 350
**This segment contains sponsored content
Some of the best business opportunities in health care will involve developing technologies that analyze and address the factors that contribute to health disparities. These opportunities have the potential to help people — especially those who remain neglected or entirely unserved by today’s health care system — maintain their health through proactive, holistic care, reducing the need for doctor and hospital visits.
Social drivers of health are the aspects of life that affect individuals’ health outside of health care itself. They account for as much as 80% of an individual’s health.
Social drivers include where you live, the state of your housing, the food you have access to, your transportation options, how much education you’ve received, your financial security, and more. For example, if your living conditions mean you don’t have nearby access to healthy food or affordable transportation to a better grocery store, don’t have access to a safe place to exercise, and can’t get much sleep because of your living conditions, you are much more likely to eat poorly, become stressed, get sick, and wind up in an emergency room.
Addressing social drivers of health is often left to government programs and policies, which are subject to political winds and lack innovation or speed. So unhealthy lifestyles — as a result of unhealthy environments — remain an enormous problem. But enormous problems are fertile ground for innovative, change-the-world founders to create new enterprises.
My wife, Andréa, and I have seen firsthand the impact of social drivers. After I retired as CEO of Merck, she and I set up a clinic to bring quality health care to my old neighborhood in a poorer section of Philadelphia. We quickly realized that many of the residents’ health problems were a result of their lack of access to fresh, healthy food. In fact, this neighborhood is what might be called a food desert. With little access to healthy food, people in the community must rely on processed, fatty foods and are more likely to eventually develop conditions like diabetes and clogged arteries.
Social drivers of health adversely affect minoritized and lower-income populations at far greater rates because they are more likely to live in neighborhoods without good grocery stores; are more likely to live in substandard conditions; and are more likely to forgo preventive care for financial and health literacy reasons.
Nearly 10% of Black Americans do not have health insurance, compared with 5% of white Americans, and lack of insurance leads people to delay medical care until a problem becomes dire. Covid-19 also made it clear that health care remains scarce in rural America. More than 180 rural hospitals have closed in the past 10 years, leaving many residents of small towns having to travel hours to see a doctor.
Improving social drivers of health has typically been a matter for public health departments. There have been some remarkable successes: effective sewage systems, safer drinking water, reduced air pollution, anti-smoking campaigns, and more have all added years to the life expectancy of everyone, including marginalized people.
But the best ways to understand and address social drivers and health inequity today are by building companies that profitably undertake solving such issues. No one company can solve it all; it will require an ecosystem of interoperating companies and technologies, and radical collaboration with existing health care systems.
A number of companies are showing the way, including Cityblock Health, a portfolio company of General Catalyst, which I work for. Founded in 2017, Cityblock uses software and partnerships with insurers and hospitals to bring health care to low-income people. The company is now worth more than $6 billion.
Another is Papa. The company realized that when seniors living alone have some companionship and a little assistance in their lives, they are less likely to get sick and require expensive medical care. So Papa built a platform to match young adults with seniors, and uses the platform to offer services such as telemedicine and chronic care management that help seniors live at home and stay out of hospitals.
Here are some of the opportunities that I believe founders of companies aiming to tackle health inequities should consider:
Data are key to health assurance — a new category of health care that uses technology to help every person stay healthy and manage their conditions so they rarely need “sick care” in a hospital or doctor’s office.
While electronic medical records contain health data like prescriptions, heart rate, and lab work, they contain almost no information about social drivers of health — and no data that connect them to other medical conditions. In other words, medical professionals have no empirical evidence that shows how their patients’ social needs affect their health.
According to a study published in Health Affairs, health care professionals are “frequently flying blind, lacking data on both their patients’ social needs and the capabilities of potential community partners.”
A company that can collect data about social drivers of health, connect them to health outcomes, and analyze the data to find better ways for people to stay healthy and manage chronic conditions would be enormously valuable. I could see a pharmaceutical company wanting to be a customer, helping it understand why medications are more or less successful in certain populations. Health insurers would also find such information valuable.
While creating such a pool of data would no doubt prove challenging, the future of health care actually depends on someone getting it right.
There is a shocking lack of any kind of consolidated database of entities that provide social services that can Boost health. A physician treating a patient who has diabetes and lives in a food desert, for example, can’t open an app and find a subsidized fresh food delivery service that could help her patient eat better.
Achieving health assurance means tying together all aspects of health. Doctors should be able to prescribe a social service that would Boost health just as easily as they prescribe a pill. The U.S. needs companies that make that possible.
In my old neighborhood, some people with diabetes don’t show up at the clinic until their condition is so bad they need to have a foot amputated because of diabetes-related circulation problems. A tool that can educate and encourage disadvantaged people to be screened for breast and colon cancer or diabetes or heart health would be extremely beneficial. Many economically disadvantaged people simply don’t know enough about their health and health care options to get the help they need before conditions get serious.
I see the need for a company that creates a health literacy application aimed at marginalized populations. The “worried well” don’t need this — they tend to research (perhaps over-research!) their health conditions and have easy access to medical care. But people who aren’t so lucky need guidance that feels like it applies to them.
It’s just not possible to train enough doctors and build enough hospitals to provide easy access to care for every American. Quality care is especially out of reach for those living in inner cities and rural towns. The solution, in this era of mobile devices and cloud computing, is virtual care.
Of course, telemedicine already exists. And during the early days of Covid-19, it seemed that it would go mainstream. But it hasn’t. Perhaps it’s like the early years of videoconferencing, when apps like WebEx were used only occasionally until the pandemic and Zoom collided and made video calls as common as voice calls. Zoom’s brilliance was in making it robust and easy to use. We need Zoom-like advances in telemedicine, and business models that make it work for rural and inner-city populations.
Our mission at General Catalyst is to partner with founders to bring to life startups that address social drivers of health and health disparities. Health assurance companies will shape the future of our collective health and wellness, bringing to bear the technologies and solutions that enable proactive, holistic care that is truly accessible to all and in service of our broader society.
Ken Frazier is chair of health assurance initiatives at General Catalyst, a venture capital firm, and the current executive chairman and former CEO of Merck. He is also the co-founder and co-chair of OneTen, a coalition of organizations committed to upskilling, hiring, and promoting one million Black Americans into family-sustaining jobs.
Whenever health-centric regulations like the 21st Century Cures Act appear on the horizon, they frequently bring up challenges and questions, along with the advancements. For example, while this legislation and other recent developments are making it easier for patient registries to gather and share patient data, many still struggle with how to best put that data to appropriate use.
To learn more about how recent regulations can be of use to stakeholders in research and drug development, Outsourcing-Pharma recently spoke with Angela Kennedy, director of strategic operations for medical special societies at IQVIA.
OSP: What is a medical specialty society?
AK: A medical specialty society, also referred to as a provider association, is a membership organization representing a specific group of healthcare professionals, for example, the American College of Surgeons. Medical specialty societies perform many important functions and services for their members, including education, advocacy, and health policy.
Medical specialty societies help Boost and facilitate quality, effective, and accessible patient care, leveraging member experience to research, develop, and implement the highest standards and practices. They also help set standards for excellence in their profession through clinical practice guidelines, quality measures, and quality improvement programs, most through the use of clinician-led clinical data registries.
OSP: How can the 21st Century Act help in collecting, sharing, and using patient data?
AK: The US 21st Cures Act (Cures Act) was signed into law by President Barack Obama on Dec. 13, 2016. The bipartisan legislation seeks to increase choice and access for patients and providers. Among many parts of its parts, The Cures Act seeks to ease regulatory burdens associated with the use of electronic health record (EHR) systems and health information technology (IT).
After the Cures Act was signed into law, it was passed to the Office of the National Coordinator for Health Information Technology (ONC) and the Centers for Medicare & Medicaid Services (CMS) for review. ONC and CMS produced two sets of rules based on the Cures Act’s interoperability, patient access, and information blocking provisions. These rules guide members of the industry, such as providers, payers, and technology vendors, as they design their health IT systems. Both the ONC and CMS rules fulfill the interoperability and information-blocking provisions of the Cures Act and are designed for increased patient access to their own information and ensure a standard of interoperability across systems.
The Cures Act resulted in new regulations that fundamentally change how patient data is accessed and repurposed. It contains provisions focused on advancing interoperability and requiring developers not to engage in information blocking — or preventing or interfering with the access, exchange, or use of electronic health information (EHI). ONC defines EHI in their final rule as “the electronic protected health information (ePHI) in a designated record set (as defined in the Health Insurance Portability and Accountability Act (HIPAA) regulations) regardless of whether the records are used or maintained by or for a covered entity.”
For the purposes of information blocking, EHI is limited to the data elements represented in the US Core Data for Interoperability (USCDI). In a major step forward, the USCDI aims to Boost interoperability of various medical data systems and enable data exchange between stakeholders such as physicians, insurers, labs, clinical data registries, and patients themselves. The final rule also has an array of requirements for standards-based application programming interfaces (APIs), with the goal to support a patient's access and control of their electronic health information.
ONC published its Information Blocking Final Rule in May 2020. The rule defines information blocking as any practice that interferes with the access, exchange, or use of EHI. The Information Blocking Rule strengthens the rights that patients have in terms of obtaining their electronic health data in the modern health IT environment. It also holds EHR vendors accountable for ensuring that health information is accessible.
The rule went into full effect on April 5, 2021, requiring providers, vendors, and any “actor” in the healthcare sector that takes part in health information exchanges to comply. At the root of the Information Blocking Rule is the desire to make electronic health data more accessible for patients or other entities as permitted by HIPAA. The Final Rule calls for the industry to support standards adoption using secure Application Programming Interface (API) functionality, the leading standard for the exchange of health information is Fast Healthcare Interoperability Resources (FHIR), and the Cures Act proposes the use of FHIR as the standard format.
Although the rule went into effect in April, healthcare organizations are not required to migrate to Fast Healthcare Interoperability Resources (FHIR) v4 APIs until December 31, 2022. As the FHIR v4 API deadline approaches, health IT vendors and providers will have to make decisions about how to operate from a clinical perspective while staying in line with the Information Blocking Rule.
CMS finalized the Interoperability and Patient Access Final Rule in March 2020, shepherding in the next phase for the Cures Act. CMS calls the new rules – which hold public and private entities accountable for enabling easy electronic access to health information – the most extensive healthcare data-sharing policies yet implemented by the federal government.
The rule requires CMS-regulated payers to implement patient access application program interfaces and provider directories, as well as increase data sharing with other payers. Together, these rules attempt to make it easier for patients to have access to and control over their health data. These final rules represent significant changes in how health care providers, health IT developers, and health plans use health IT.
OSP: Are there any ways in which the 21st Century Cares Act and other legislation/agencies might fall short in supporting and guiding?
AK: Even though the Cures Act interoperability and information-blocking requirements and subsequent regulations are designed to move the healthcare industry towards greater data access, the long phase-in of these provisions comes with challenges. The requirement is to move towards a more transparent system, but a significant amount of specific guidance compliance and enforcement details are not yet established.
More than a year after the public release of the Final Rule, confusion about information blocking remains widespread. CMS has not yet provided clarity about the potential penalties that could be imposed on providers for noncompliance, and the Office of Inspector General (OIG) has not finalized its proposed penalties for certified EHR vendors and health information exchanges. Finalization of some of those enforcement aspects and a lot more clarity is absolutely essential.
OSP: Why is capturing a more complete picture of a patient’s health history help innovation in drug development? Also, how can it help Boost efficiency in various aspects of drug development?
AK: In November 2021, Congress introduced Cures Act 2.0. In Section 309 of the Cures 2.0 Act, which seeks to increase the use of real-world evidence and support the use of data from clinical care data repositories and patient registries to fulfill post-approval study requirements for products regulated by the Food and Drug Administration. This legislation is designed to modernize the health care delivery system and better utilize real-world data and real-world evidence across federal agencies.
Cures 2.0 also discusses the acceptance of decentralized trials. Clinical trials are necessary to bring safe and effective drugs and devices to the market. However, many drugs and devices are developed on small populations in laboratory-controlled settings that may not be reflective of real-life experience with a disease. Decentralized clinical trials, on the other hand, are conducted in a study participant’s home using digital tools. These can include more sensitive, objective measures with greater density of information, and can include many more study participants.
Although fully decentralized trials are not appropriate for all research, in many instances, decentralized trials can deeply enrich a study and the FDA should support the use of such trials.
Digital tools should not be validated by the FDA alone, but in collaboration with an appropriate medical specialty society, clinical expert, or physician informaticist to reinforce physician trust in the tool. Use and validation of digital health tools are two of the most critical areas for physicians to successfully realize the potential of these technologies.
OSP: Then, how can capturing more complete patient health stories Boost patient engagement and care?
AK: The Cures 2.0 Act builds upon provisions of the 21st Century Cures Act that underscore how clinician-led clinical data registries are uniquely positioned to drive quality improvement initiatives. Cures 2.0 incorporates the 21st Century Cures Act’s definition of “clinician-led clinical data registry” as a clinical data repository that is established or operated by a clinician-led or controlled, medical specialty society or other similar organization; designed to collect detailed, standardized data on an ongoing basis for medical procedures, services, or therapies for particular diseases, conditions, or exposures; provides feedback to participating data sources; and meets certain quality standards.
Section 411 in the Cures 2.0 Act, which would ensure that clinician-led clinical data registries have meaningful access to real-world data (RWD) to better track patient outcomes over time, expand their ability to assess the safety and effectiveness of medical treatments, and provide them with the information necessary to assess the cost-effectiveness of therapies. This legislation would allow clinician-led clinical data registries to link their outcomes data with claims data in a way that would help ascertain the value of new medical technologies and therapies and assist in the development of effective alternative payment models (“APMs”).
The worldwide Mussel Extract Market size is anticipated to arrive at US$ 71.30 Million by 2032. The Mussel Extract market is developing essentially.
Mussel Extract is a concentrate that is extricated from a mussel a little ocean animal having two shells firmly stuffed together. Because of expansion in populace and to address the issues of fish, the hydroponics business has laid out numerous hydroponics lakes, which expands the quantity of the development of new mussels, for getting pearls and other results.
Mussels are raised in freshwater as well as seawater as per the customer’s necessity. There is a rising interest in Mussel Extract because of its huge medical advantages and skin health management, as would be considered normal to help the Mussel Extract market essentially.
Alongside the advantages to people, it is additionally gainful for canines. Many pet sweethearts lean toward Mussel Extract containing nourishment for sound bones and expansion in omega-3 admissions of canines, which expands their well-being and life expectancy. Expanding well-being and cardiovascular dangers lead numerous customers toward well-being awareness to control muscle versus fat and keep themselves sound.
Hence buyers to be sound and away from cardiovascular gamble favor the fish Mussel Extract in food, which is wealthy in omega-3, helpful for the heart and valuable in forestalling aggravation, caused because of bone debasement, attributable to such reasons the mussel remove is supposed to develop essentially over the gauge period.
Expanding Demand for Mussel Extract Due to Various Health Benefits
The popularity of mussels differs from one country to another, with developing medical problems, for example, joint inflammation, and bone sicknesses, buyers are getting well-being cognizant and moving towards the well-being gainful food fixing, for example, Mussel Extract. Mussel removal helps further develop nerve cell work and expands bone and tissue responsiveness.
Mussel Extract is utilized in different enhancement items, for example, helping resistance supplement, and dietary enhancements, Due to expanding contamination prompting unsafe climate and an exceptionally chaotic workplace, and utilization of tobacco and liquor, is extending barrenness in men and lady, Mussel Extract is gainful in expanding fruitfulness alongside the safe power in buyers.
It carries more popularity in the mussel removal market, numerous producers are as of now utilizing Mussel Extract as their diminished fixing, because of expanding medical advantages and purchasers’ requests. There is more popularity for Mussel Extract in the creature feed producing industry to work on the healthful substance for creature takes care of.
Mussel Extract Market: Key Players
A portion of the top makers and providers of mussel removal are Waitaki Biosciences International Ltd., Maclab, Inc., Nature’s Path Foods, Inc., Great HealthWorks Inc., Navchetana Kendra Agra., and so on are some driving producers of Mussel Extract.
Get a trial Copy
The following is a press release from Texas Tech University:
LUBBOCK, Texas (PRESS RELEASE) — A Texas Tech University faculty member is helping to show the world that peanuts may be a useful dietary addition in dealing with a variety of health needs.
A new study from the University of South Australia found consumption of lightly salted peanuts twice a day before meals led to weight loss, lowered blood pressure and improved fasting glucose levels. The findings were recently published online in the peer-reviewed journal Nutrients and shared by The Peanut Institute.
The two-arm, parallel randomized controlled trial was conducted from January to December 2021 and led by two professors from the University of South Australia. Kristina Petersen, assistant research professor in Texas Tech’s Department of Nutritional Sciences was a collaborator.
“Our study found that peanuts, which are high in healthy unsaturated fats, can actually aid weight loss,” Petersen said. “Peanuts are often avoided when people are trying to lose weight because they believe peanuts contain too many calories. However, peanuts actually have a high satiety value, meaning they keep you feeling fuller longer and that can be really helpful for those on a weight loss diet.”
The study included two groups of Australian adults who were at moderate or high risk for type 2 diabetes. Both groups received weight loss education. The control group of 50 adults was instructed to avoid eating any nuts or nut butter. The peanut-enriched group of 57 adults consumed 35 grams of lightly salted, dry-roasted peanuts twice a day 30 minutes before meals.
After six months, researchers found:
It’s widely understood that foods high in protein and fiber deliver a feeling of fullness that can help reduce the urge to snack or overeat. Peanuts are considered a protein powerhouse since a one-ounce serving delivers seven grams of protein, nearly 3 grams of fiber and 19 vitamins and minerals. In this study, the peanut-enriched group was getting approximately an extra 15 grams of protein just from their consumption of peanuts.
Even though the peanuts were lightly salted, participants still saw improved systolic blood pressure compared to those in the control group. Petersen offers a potential explanation for this seemingly contrary result:
The Australian study also found the peanut-enriched group experienced improved glucose levels, which is consistent with previous research.
Based in Albany, Ga., The Peanut Institute is a nonprofit organization supporting nutrition research and developing educational programs to encourage healthy lifestyles that include peanuts and peanut products. The Peanut Institute pursues its mission through research programs, educational initiatives and the promotion of healthful lifestyles to consumers of all ages.
(Press release from Texas Tech University)
Express News Service
TIRUCHY: As many as 33 locations in the city, where accident cases are comparatively high, have been identified as part of the study taken up jointly by the State government and IIT-Madras to come up with a comprehensive road safety framework for Tamil Nadu.
Following a recent MoU between the State government’s Special Task Force for Road Safety and IIT-Madras, the STF has constituted a Field Survey Team (FST) in every district which has since August 1 been monitoring and ascertaining the causes behind accidents in the selected areas.
According to sources, the FST would comprise a police official, a highway official, a village administrative officer (VAO), a corporation official, an emergency medical technician, a civil engineering professor, and three students of civil engineering.
In Tiruchy district, B Joseph Nixon, Assistant Commissioner of Police, North traffic range, has been appointed the nodal officer to head the FST. Pointing to 33 places identified in the city for the study, Nixon said the FST would scientifically analyse the spots in every possible aspect.
The geographic features, structure, and characteristics and landmarks in the roads in the identified locations would be noted, he added. The details would then be uploaded to a custom-made app, 'Field Survey Mobile App', which would then be reviewed by the collector, city police commissioner, and the corporation commissioner, the ACP pointed out.
The details from the review would be sent to the State-level officers, who would furnish the solutions to the issues. Stressing on the FST’s inclusivity, Nixon pointed out an example of how the civil team marked the lack of street lights as cause for most accidents in a location. This would be recorded in the app, he said, and added that many similar aspects like animal straying and crowding have been uploaded as well.
B Shridevi, DCP (South), Tiruchy, said the FST would identify the engineering defects and the enforcement requirements, and suggest solutions that would help in bringing down the accident rate in the identified places. Nixon said so far, 30 of the 33 identified locations have been studied and the remaining would be covered before August 10. The process is much simpler as the State team would be directing the authorities concerned directly which, in turn, would pay the way for rapid action, he added.